Clinical trial
The Effect of High-dose Silybin-phytosome in Men With Prostate Cancer
NCT00487721 · University of Colorado, Denver, Other · Completed
Key facts
| NCT number | NCT00487721 |
|---|---|
| Title | The Effect of High-dose Silybin-phytosome in Men With Prostate Cancer |
| Official title | A Pilot Biomarker Study of Oral Silybin-Phytosome Followed by Prostatectomy in Patients With Localized Prostate Cancer |
| Lead sponsor | University of Colorado, Denver, Other |
| Collaborators | Sir Mortimer B. Davis - Jewish General Hospital |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Silibin-Phytosome |
| Enrollment | 12 |
| Start date | Aug 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Nov 1, 2010 |
| First posted | Jun 19, 2007 |
| Last update posted | Mar 31, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: